Status: Recruiting
A Clinical Trial to Evaluate the Safety and Efficacy of Neuromodulation Using 'ExAblate 4000 Type 2.1' in Patients With Psychostimulant Use Disorder(PUD)
The purpose of this clinical trial is to evaluate the initial safety and efficacy of the ExAblate Model 4000 Type 2.1 surgical device for nucleus accumbens (NAc) neuromodulation in patients with psychostimulant use disorder (PUD).
Participants needed: 10
Trial details
Age: 19-60Biological sex: AllType: InterventionalSponsor: Korea University Anam HospitalUpdated: Sep 5, 2025Locations: 1
Eligibility criteria
Adults between the ages of 19 and 60 [+8]
Subject with standard contraindication for MR imaging, such as non-MRI compatibl... [+32]